跳至主要内容
临床试验/CTRI/2021/04/032904
CTRI/2021/04/032904尚未招募不适用

To study the clinical outcomes in hospitalized patients, receiving Remdesivir for moderate/severe COVID 19 infection, during August 2020 to October 2020 in a designated COVID hospital.

Dr Punam Bhende1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2021年4月20日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
150
试验地点
1
主要终点
Death, Discharge, Length of stay in hospital, duration of O2therapy

研究概览

简要总结

This is an observational study, wherein we will go through records of patients admitted with moderate and severe COVID infection in our hospital and received remdesivir ,during the period specified. Comorbidities, age, duration of symptom onset and presentation to the hospital will be noted. Hospital stay, outcome- discharge/ death/ duration of oxygen requirement will also be studied.

This is to see the clinical outcomes in patients receiving Remdesivir.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • 未提供

排除标准

  • Not Applicable.

结局指标

主要结局

Death, Discharge, Length of stay in hospital, duration of O2therapy

时间窗: 3 months

次要结局

  • the results will help in decision making and add to existing treatment protocols(3 months)

研究者

发起方
Dr Punam Bhende
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验